Translating Genetic Knowledge Into Clinical Care in Non-Autoimmune Diabetes
Launched by UNIVERSITY OF COPENHAGEN · May 5, 2022
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The TRANSLATE project is an integrative project with multifaceted goals, that can be broken down into two main columns. The foundation for both columns is the WGS analysis in a clinical diagnostic setting in order to guide patient treatment. Patients are not randomized and the inclusion and exclusion criteria are deliberately broad and minimal, respectively.
The first column is the clinical development project, which seeks to complete a novel diagnostic process. This column will develop new pipelines and uncover barriers and challenges associated with gene-based precision medicine to facil...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Any case of non-T1D defined as debut \>30 years of age, OR debut \<30 years of age AND negative autoantibodies
- • Any case of diabetes diagnosed in pregnancy (obstetric departments)
- Exclusion Criteria:
- • Age \<18 years
- • Inability to provide informed consent
About University Of Copenhagen
The University of Copenhagen, a leading research institution in Denmark, is dedicated to advancing medical knowledge and improving patient outcomes through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its expertise in various fields, including health sciences, pharmacology, and biotechnology, to design and conduct rigorous clinical studies. Committed to ethical standards and scientific integrity, the University of Copenhagen aims to contribute significantly to the global medical community by facilitating groundbreaking research that addresses pressing healthcare challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hvidovre, , Denmark
Copenhagen, , Denmark
Herlev, , Denmark
Hillerød, , Denmark
Herlev, , Denmark
Patients applied
Trial Officials
Torben Hansen, PhD
Principal Investigator
University of Copenhagen
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials